ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,308.13
0.09%
Dow Jones
39,806.77
-0.49%
US Dollar vs MXN
16.54825
-0.04%
Brent Oil
82.825
-0.84%
Bitcoin
70,980.76
-0.66%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Amicus Therapeutics Inc (FOLD)

  7. Amicus Therapeutics Inc (FOLD) Noticias

FOLD

Amicus Therapeutics (FOLD)

Amicus Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:FOLD
FechaHoraFuenteTítuloSímboloCompañía
09/05/202415:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FOLDAmicus Therapeutics Inc
09/05/202406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FOLDAmicus Therapeutics Inc
09/05/202406:00GlobeNewswire Inc.Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:FOLDAmicus Therapeutics Inc
08/05/202406:00GlobeNewswire Inc.Amicus Therapeutics to Present at the Bank of America 2024 Health Care ConferenceNASDAQ:FOLDAmicus Therapeutics Inc
01/05/202406:00GlobeNewswire Inc.Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024NASDAQ:FOLDAmicus Therapeutics Inc
20/03/202406:00GlobeNewswire Inc.Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) ReportNASDAQ:FOLDAmicus Therapeutics Inc
11/03/202416:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
05/03/202415:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
01/03/202406:00GlobeNewswire Inc.Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024NASDAQ:FOLDAmicus Therapeutics Inc
28/02/202406:00GlobeNewswire Inc.Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate UpdatesNASDAQ:FOLDAmicus Therapeutics Inc
15/02/202406:00GlobeNewswire Inc.Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024NASDAQ:FOLDAmicus Therapeutics Inc
14/02/202415:38Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:FOLDAmicus Therapeutics Inc
08/02/202406:00GlobeNewswire Inc.Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™NASDAQ:FOLDAmicus Therapeutics Inc
01/02/202406:00GlobeNewswire Inc.Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024NASDAQ:FOLDAmicus Therapeutics Inc
07/01/202415:00GlobeNewswire Inc.Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic OutlookNASDAQ:FOLDAmicus Therapeutics Inc
03/01/202406:00GlobeNewswire Inc.Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:FOLDAmicus Therapeutics Inc
05/12/202305:00GlobeNewswire Inc.Amicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIONASDAQ:FOLDAmicus Therapeutics Inc
08/11/202316:25Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:FOLDAmicus Therapeutics Inc
08/11/202306:00GlobeNewswire Inc.Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate UpdatesNASDAQ:FOLDAmicus Therapeutics Inc
01/11/202306:00GlobeNewswire Inc.Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023NASDAQ:FOLDAmicus Therapeutics Inc
27/10/202306:00GlobeNewswire Inc.Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023NASDAQ:FOLDAmicus Therapeutics Inc
16/10/202315:56Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:FOLDAmicus Therapeutics Inc
03/10/202306:00GlobeNewswire Inc.Amicus Therapeutics Announces Presentation and Posters at World Muscle Society 2023NASDAQ:FOLDAmicus Therapeutics Inc
02/10/202307:20GlobeNewswire Inc.Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing CollaborationNASDAQ:FOLDAmicus Therapeutics Inc
01/10/202319:30PR Newswire (US)WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe DiseaseNASDAQ:FOLDAmicus Therapeutics Inc
28/09/202310:31Dow Jones NewsAmicus Therapeutics Gets FDA Approval for Pombiliti + OpfoldaNASDAQ:FOLDAmicus Therapeutics Inc
28/09/202309:41GlobeNewswire Inc.Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe DiseaseNASDAQ:FOLDAmicus Therapeutics Inc
01/09/202306:00GlobeNewswire Inc.Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2023NASDAQ:FOLDAmicus Therapeutics Inc
29/08/202306:00GlobeNewswire Inc.Amicus Therapeutics Announces Presentation and Posters at the SSIEM Annual Symposium 2023NASDAQ:FOLDAmicus Therapeutics Inc
23/08/202316:46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FOLD

Su Consulta Reciente

NYSE
CVX
Chevron
NYSE
DIS
Walt Disney
USOTC
ADDYY
Adidas (QX)
NYSE
XOM
Exxon Mobil
NYSE
KO
Coca Cola
USI
USTECH100
US Tech 100
AMEX
XLE
Energy Select Sector SPDR
COIN
ETHUSD
Ethereum
USOTC
BASFY
BASF (QX)
COIN
SOLUSD
Solana
NYSE
AXP
American Express
SPI
SP500
S&P 500
USOTC
RHHBY
Roche (QX)
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLF
Financial Select Sector
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados